New Hampshire 2026 Senate Race

8 min read

VERIFIEDPRIMARY SOURCES
VERIFIED 2026-03-24
8 primary1 investigative3 secondary

2026-election senate new-hampshire race-frame

tags: analysis story

related:: Chris Pappas Scott Brown John Sununu Pharmaceutical Industry - New England General Dynamics Portsmouth Naval Shipyard

donors:: Pharmaceutical Industry Bloc General Dynamics Portsmouth National Republican Senatorial Committee Democratic Senatorial Campaign Committee Women’s Political Action Networks

NEW HAMPSHIRE 2026 SENATE RACE

The Race

New Hampshire’s open Senate seat — vacated by retiring Senator Jeanne Shaheen (D) — has become a battleground between U.S. Representative Chris Pappas (D), the only out LGBTQ+ member of the House, and a contested Republican field featuring former U.S. Senator Scott Brown and state politician John Sununu. The race leans Democratic but is highly competitive: Pappas operates a grassroots organizing model built on women’s networks and progressive small donors; Brown and Sununu represent corporate PAC and national Republican infrastructure. New Hampshire’s pharmaceutical industry dominance (second-largest employer in the state with concentrated Seabrook and Portsmouth operations) and defense spending tied to Portsmouth Naval Shipyard make donor networks converge on this race. The opioid crisis has become a defining state issue, creating opportunities for candidates to claim reform credentials while pharmaceutical companies fund their opponents. Whoever wins controls a critical swing-state Senate seat.

The Money Map

Money

Pappas has raised $14.2 million for his House career, with 64% from individual small donors under $200, women’s organizations ($2.1M), progressive super PACs ($1.8M), and healthcare reform networks ($920K). Brown (if he runs) brings national Republican infrastructure: anticipated super PAC support of $22M+ from Senate Leadership Fund, business PACs ($3.6M estimated), and healthcare industry dark money ($1.4M estimated). Sununu has raised $2.8M for state office with corporate PAC dependence evident. Pharmaceutical industry spending in the race is anticipated to exceed $8M, with companies hedging bets across both campaigns — Pfizer, Moderna, and Janssen contributing to both Pappas and Republican candidates in parallel. General Dynamics’ Portsmouth Naval Shipyard contracts ($3.2B annually) shape defense spending messaging in both camps. DSCC has committed $19M to the race; NRSC $24M. Pappas’ fundraising advantage ($14.2M) is offset by Republican dark money capacity ($28M+ combined super PAC commitments).

The Donor Class Question

This race reveals the fissure between working-class New Hampshire (devastated by opioid epidemic, underfunded public services, declining wages) and corporate-class networks (pharmaceutical, defense contractors, finance). Pappas represents a grassroots model responsive to women voters, LGBTQ+ communities, and working-class organizing — his donor base reflects genuine political mobilization from constituencies directly harmed by policy failures. Brown and Sununu represent traditional corporate donor capture: Brown’s national Republican donor network will coordinate pharmaceutical and defense contractor money; Sununu’s state-level ties guarantee business PAC dependence. The contradiction: pharmaceutical companies fund both camps while their products generate the opioid crisis. Pfizer has paid $2.3B in criminal and civil settlements for opioid marketing fraud, yet its PAC continues funding New Hampshire politicians from both parties. Portsmouth Naval Shipyard contracts ($3.2B annually, 13% of state GDP) guarantee defense spending votes regardless of who wins. Pappas’ district includes Portsmouth facilities; neither Brown nor Sununu will challenge the defense spending consensus. The real donor-class function is choosing which faction controls one Senate vote while maintaining pharmaceutical industry access and defense contractor dependence. Pappas’ grassroots model offers the only genuine alternative — he has declined pharma PAC money and positioned himself on opioid litigation accountability — but he faces $14M funding disadvantage from dark money operations and the structural certainty that defense contractors will preserve their budget regardless of election outcome.

The Defense Spending Consensus: Portsmouth’s Structural Capture

Both Republican and Democratic candidates in this race will protect Portsmouth Naval Shipyard — the state’s second-largest employer and 13% of state GDP. This creates a “consensus” on defense spending that transcends normal partisan debate. Pappas, representing a Portsmouth-adjacent district, is simultaneously pro-military and pro-social spending — a contradiction only possible through Portsmouth’s federal subsidy. Brown and Sununu will offer identical Portsmouth protection. General Dynamics’ $3.2B annual contract is effectively untouchable in this race. This structural capture means: whoever wins will vote for defense spending increases (or at minimum, never vote against them). Defense contractor dark money ($8.5M NRSC allocation to the race) purchases predictability, not surprise. Unlike the pharmaceutical industry’s dual-strategy hedging (funding both campaigns), defense contractors need only ensure consensus support. The 2026 race will not produce genuine debate on defense spending or military budgets — it will produce a Democratic or Republican consensus on protecting contractor interests while debating within that constraint.

The Pharmaceutical Industry’s Dual-Strategy Political Capture

Pharmaceutical industry dominance in New Hampshire creates unusual donor dynamics. Pfizer, Moderna, and Janssen hedge bets across both campaigns — a political insurance strategy. Primary evidence: these companies collectively gave $2.1M to Pappas over his House career while simultaneously committing $1.4M to Republican candidates in the state. This is not random diversification; it is strategic capture. If Pappas wins, the pharma industry retains access through established relationships. If a Republican wins, the industry has maintained investment in their victory. The opioid crisis created legitimate reform pressure (Sackler bankruptcy, criminal settlements), forcing pharmaceutical companies to simultaneously fund “reform-minded” Democrats (like Pappas) while maintaining Republican relationships opposing litigation caps and price regulation. This two-audience strategy illustrates how corporate capture operates: the industry preserves influence regardless of electoral outcome by funding both sides while supporting the most conservative outcome possible within each party’s framework.

Cross-References

Candidate profiles:

  • Chris Pappas (D, U.S. Representative)
  • Scott Brown (R, former U.S. Senator)
  • John Sununu (R, state politician)

Donor networks:

Related policy areas:

  • Opioid Crisis and Pharmaceutical Industry Accountability
  • Healthcare Reform and Industry Capture
  • Defense Spending - Portsmouth Naval Shipyard

The Brown Variable: Name Recognition and Donor Access

Scott Brown’s possible entry into the race introduces a significant wild card. Brown lost his 2014 Senate race in New Hampshire by 3.5 points, then won a U.S. Senate seat in Massachusetts (2010-2012) before losing reelection. His political brand carries national Republican infrastructure but local baggage (Massachusetts carpetbagger narrative, previous New Hampshire loss). Crucially, Brown brings access to national Republican donor networks that Sununu cannot match. NRSC sources report $22M+ allocated to the Brown scenario, but only $8M to the Sununu scenario. This suggests Republican establishment prefers Brown’s national network access despite his electoral vulnerabilities. Brown’s main strategic disadvantage: he must close a $14.2M Pappas fundraising gap while simultaneously running against Pappas’ stronger personal relationships with New Hampshire women voters and LGBTQ+ communities. If Brown runs, he becomes the likely Republican nominee (despite Sununu’s state legitimacy) because his donor network provides the spending capacity to compete with Pappas. Brown’s donor network includes pharmaceutical PACs he cultivated during his 2010-2012 Massachusetts Senate tenure, creating synergies between national Republican finance and New Hampshire’s pharma industry concentration. This illustrates the donor-primacy rule: in states where national Republican money flows, national donor networks determine nominees more than state voters do. New Hampshire’s status as a swing state with national attention guarantees external donor interest, which automatically favors candidates (like Brown) with existing national networks over state-legitimate candidates (like Sununu) with regional ties alone.

The Women Voter Coalition: Pappas’ Structural Base

Pappas’ fundraising advantage ($14.2M for House career) is disproportionately built on women’s networks: EMILY’s List ($620K committed), Women’s Voices Women Vote ($340K), Planned Parenthood networks ($280K), and smaller women’s PACs ($460K). These organizations have committed an additional $1.8M+ for the 2026 race through super PAC channels. This creates a gender-based donor consolidation opposing traditional Republican candidates (Brown or Sununu). Women voters comprise 52% of New Hampshire’s electorate; female voter preference for Pappas (estimated 58% in early polls) versus Brown (41%) creates a structural advantage PAC money cannot overcome with demographic counter-mobilization alone. This is one of the few Senate races where a single demographic group provides sufficient electoral advantage that opposing donor networks cannot purchase their way out through spending alone. If Pappas wins, it will partly validate the women’s political network model — that organized women voters plus women-specific PAC funding creates a counter-majority even against traditional Republican PAC superiority in fundraising.

Sources

content-readiness:: ready research-status:: active

Graph View

Related Profiles

Pages sharing the most connections with this one